J. Bojadzieva

发表

Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic

Parijatham S. Thomas, L. Strong, B. Amini, 2018, Familial Cancer.

Risk of differential cancer types over age in families with Li-Fraumeni syndrome: a validation study using multi-center cohorts

David M. Thomas, L. Strong, S. Savage, 2019, bioRxiv.

Penetrance of different cancer types in families with Li-Fraumeni syndrome: a validation study using multi-center cohorts.

David M. Thomas, L. Strong, C. Amos, 2019, Cancer research.

Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni Syndrome

L. Strong, Ying Yuan, Wenyi Wang, 2017, Journal of the American Statistical Association.

A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome

V. Johnson, L. Strong, J. Garber, 2020, bioRxiv.

Early onset HER2‐positive breast cancer is associated with germline TP53 mutations

Diane D. Liu, O. Olopade, G. Hortobagyi, 2012, Cancer.

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis

David M. Thomas, R. Eeles, L. Strong, 2017, JAMA oncology.

Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition

Sharon Sand, Judy Garber, Xianhua Kong, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Estimating TP53 Mutation Carrier Probability in Families with Li–Fraumeni Syndrome Using LFSPRO

David M. Thomas, L. Strong, S. Savage, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants.

Robert J. Weatheritt, Stephanie L. White, N. Brown, 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome

L. Strong, S. Peterson, Martha Askins, 2017, Genetics in Medicine.

Penetrance estimates over time to first and second primary cancer diagnosis in families with Li-Fraumeni syndrome: a single institution perspective.

L. Strong, C. Amos, J. Ning, 2019, Cancer research.

Risk of multiple primary cancer diagnosis over age in families of Li-Fraumeni syndrome: a single institution perspective

L. Strong, C. Amos, J. Ning, 2019, bioRxiv.

Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome.

L. Strong, J. Ning, Wenyi Wang, 2018, Biostatistics.

Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic

Parijatham S. Thomas, L. Strong, B. Amini, 2017, Familial Cancer.